Trials / Completed
CompletedNCT02231203
Effect of Omega-3 Fatty Acids on the Perioperative Immune Response and Erythrocyte Function
Effect of Intravenous Omega-3 Fatty Acids on the Perioperative Immune Response and Erythrocyte Function in Patients With Colon Cancer
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Medical Center Alkmaar · Academic / Other
- Sex
- All
- Age
- 60 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Ideally, the postoperative inflammatory response is part of a well-orchestrated mechanism that contributes to tissue healing and rapid recovery. An exaggerated uncontrolled inflammatory response, however may lead to catabolism, tissue damage and organ failure. Omega-3 fatty acids may provide a means to alter cellular immune responses to the benefit of the patient. When omega-3 fatty acids are incorporated into membranes of inflammatory cells, they trigger intracellular signalling pathways that result in a less pro-inflammatory response. They modify gene and protein expression, modulate membrane protein activity and act as a reservoir for bioactive molecules. They also have a strong anti-inflammatory effect by mediating resolution of the inflammation. Furthermore, omega-3 fatty acids improve erythrocyte function, which is vital for an adequate microcirculation, tissue oxygenation and wound healing. The investigators hypothesize that the perioperative administration of intravenous omega-3 fatty acids results in a rapid incorporation in immune cells and erythrocytes, thereby reducing the postoperative inflammatory response and improving erythrocyte function in patients undergoing colorectal surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omegaven | 2 infusions, 2 ml/kg, one the night before operation and one the day after operation |
| DRUG | Placebo | 2 infusions, 2 ml/kg, one the night before operation and one the day after operation |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2014-09-04
- Last updated
- 2018-07-31
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02231203. Inclusion in this directory is not an endorsement.